Welcome
NMT Pharmaceuticals Pte Ltd (NMT Pharma) is a Singapore-based company with more than 10 years of experience in drug delivery and formulation development. NMT Pharma is wholly-owned by NMT Holding Pte Ltd and a Read more
News
NMT PHARMA has participated in CPhI Worldwide held from 4th to 6th October 2016 at Fira de Barcelona Gran Via Conference Centre. The event hosted more than 36,000 visiting pharma professionals over Read more
News
NMT PHARMA was invited to present its applications of nanotechnology in pharmaceuticals in the 2016 International Forum on Advanced Materials (IFAM) held from 24th to 26th September 2016 at Nanjing Read more
News
Visit NMT Pharmaceuticals at stand 3B50! We are pleased to inform you that we will be exhibiting at CPhI Worldwide, ICSE, InnoPack, P-MEC and FDF 2016 from 4 - 6 October 2016 in Fira Gran Via, Read more
News
NMT Pharmaceuticals Singapore Announces Signing of Licensing Agreement with CAO Pharmaceuticals USA on Anti-cancer Drug CZ-48 and Initiation of Phase I Read more
News
NMT Pharmaceuticals Singapore Announces Signing of Licensing Agreement with CAO Pharmaceuticals USA on Anti-cancer Drug CZ-48 and Initiation of Phase I Read more
News
NMT Pharmaceuticals Singapore Announces signing of Letter of Intent with CAO Pharmacueticals USA in Licensing and Development of Anti-cancer Drug CZ-48   Singapore, August 24, 2015 – NMT Read more
News
Micro-Sphere Switzerland and NanoMaterials Technology Singapore announces technology partnership to provide particle nanonization-spray drying services   Switzerland, January 14, 2014 – Read more
News
NanoMaterials Technology Singapore Signs Clinical Trial Material Supply Agreement for Anti-cancer Drug with CHRISTUS Stehlin Foundation for Cancer Research   SINGAPORE, October 14, 2013 Read more
News
NanoMaterials Technology Participates in Nanotech Japan 2013 [fvplayer src="http://newnmt.memordial.com/wp-content/uploads/2016/01/2013-Nanotech-Japan-Award.mp4" width="400" Read more
News
NanoMaterials Technology Signs Exclusive Licensing Agreement for Hyperlipidemia-controlling Drug with Beijing Winsunny Pharmaceutical   Singapore, April 8, 2010 – NanoMaterials Read more